CD4 and liver disorder: However, during the follow-up there was an increase in TEMRA CD4+ T cells (1.24 ± 1.16% vs. 2.14 ± 1.14%, p = 0.03) in patients with AC, and a decrease of Th17 cells (14.16% ± 4.31 vs. 12.35% ± 6.40, p = 0.03) in patients without liver disease.